# The Safety and Pharmacokinetics Study of TAKC-02 Inhalation Solution in Healthy Adult Males.

> **NCT05018533** · PHASE1 · COMPLETED · sponsor: **TAK-Circulator Co.** · enrollment: 52 (actual)

## Conditions studied

- Healthy Volunteer

## Interventions

- **DRUG:** TAKC-02
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05018533
- **Lead sponsor:** TAK-Circulator Co.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-08-17
- **Primary completion:** 2021-12-28
- **Final completion:** 2021-12-28
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2022-06-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05018533

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05018533, "The Safety and Pharmacokinetics Study of TAKC-02 Inhalation Solution in Healthy Adult Males.". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05018533. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*